[144] Addus HomeCare Corp. SEC Filing

Rhea-AI Filing Summary

Addus HomeCare Corp. (ADUS) Form 144 notifies the proposed sale of 7,739 common shares through Morgan Stanley Smith Barney on 08/25/2025 on NASDAQ with an aggregate market value of $904,114.87. The filing shows 18,407,239 shares outstanding. The shares to be sold were recently acquired as restricted stock from the issuer on 02/22/2025 (2,792 shares), 02/23/2025 (1,881 shares) and 02/24/2025 (3,066 shares), with payment noted as Not Applicable. The filer reports no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Filer disclosed material transaction details including acquisition dates, broker, sale date, number of shares, and aggregate market value
• No securities sold in the prior three months by the person for whose account the sale is proposed, as stated in the filing

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Form 144 discloses a planned sale of newly issued restricted shares; no prior sales reported in past three months.

The filing is a standard Rule 144 notice showing a proposed transaction of 7,739 common shares acquired as restricted stock over three consecutive dates in February 2025. The broker-dealer is identified and the trade is scheduled for a single date. There are no reported sales by the same person in the prior three months, which limits immediate market-impact history in this filing. Given the sizes disclosed, the sale represents a de minimis portion of the issuer's outstanding shares, and the filing contains the customary attestation regarding material undisclosed information.

Corporate Governance Expert

TL;DR: Disclosure is complete for a Rule 144 notice and includes required attestations; filing shows restricted grants were the source of shares.

The document appropriately lists acquisition dates, nature of acquisition (restricted stock), broker details, proposed sale date, and aggregate market value. It also states there were no sales in the prior three months. The inclusion of the statutory attestation and signature warnings aligns with compliance norms for insider sales under Rule 144. From a governance perspective, the notice fulfills transparent reporting obligations but does not provide context on vesting or any trading plan.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7739	904114.87	18407239	08/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/24/2025	Restricted Stock	Issuer			3066	02/24/2025	Not Applicable
Common	02/23/2025	Restricted Stock	Issuer			1881	02/23/2025	Not Applicable
Common	02/22/2025	Restricted Stock	Issuer			2792	02/22/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Addus HomeCare (ADUS) Form 144 disclose?

The filing discloses a proposed sale of 7,739 common shares via Morgan Stanley Smith Barney on 08/25/2025 with aggregate market value of $904,114.87.

When were the shares being sold acquired according to the Form 144?

The shares were acquired as restricted stock on 02/22/2025 (2,792), 02/23/2025 (1,881) and 02/24/2025 (3,066).

How many Addus shares are outstanding per the filing?

The filing lists 18,407,239 shares outstanding.

Did the filer report any securities sold in the past three months?

No; the filing states 'Nothing to Report' for securities sold during the past three months.

On which exchange is the proposed sale planned?

The proposed sale is planned on NASDAQ via Morgan Stanley Smith Barney.